Recombinant Human IGFBP-7 protein (His Tag)
ED50
/
Species
Human
Purity
>90 %, SDS-PAGE
GeneID
3490
Accession
Q16270-1
验证数据展示
Technical Specifications
Purity | >90 %, SDS-PAGE |
Endotoxin Level | <1.0 EU/μg protein, LAL method |
Biological Activity |
Not tested |
Source | HEK293-derived Human IGFBP-7 protein Ser27-Leu282 (Accession# Q16270-1(K95R))with a His tag at the N-terminus. |
Predicted Molecular Mass | 27.3 kDa |
SDS-PAGE | 30-35 kDa, reducing (R) conditions |
Formulation | Lyophilized from sterile PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
Reconstitution | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
Storage |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
Background
IGFBP7, also named as MAC25, PSF, IBP-7 and TAF,is a member of the insulin-like growth factor (IGF)-binding protein (IGFBP) family. IGFBPs bind IGFs with high affinity, and regulate IGF availability in body fluids and tissues and modulate IGF binding to its receptors. This protein binds IGF-I and IGF-II with relatively low affinity, and belongs to a subfamily of low-affinity IGFBPs. It also stimulates prostacyclin production and cell adhesion. Alternatively spliced transcript variants encoding different isoforms have been described for this gene, and one variant has been associated with retinal arterial macroaneurysm.
References:
1. Oh Y, et al. (1996) J Biol Chem. 271(48):30322-5. 2.Akaogi K, et al. (1994) Biochem Biophys Res Commun. 198(3):1046-53.